The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Image of the Month
On-chip Spectrometer for Low-Cost Optical Coherence Tomography
OCTANE-860 PLC (2.2×3.6 cm) containing planar concave grating (PCG) dispersive element.
Tornado Spectral Systems, Ithaca, New York, U.S.A.
NSTI Online Community